Related Experiment Videos
ISPOR's Initiative on US Value Assessment Frameworks: Seeking a Role for Health Economics
1Centre for Health Economics, University of York, York, UK.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Bayesian Dynamic Borrowing to Enhance Evidence for New Therapies.
PharmacoEconomics·2026
What is the Value of Developing an HTA Process?
PharmacoEconomics·2026
Insights from Financial Economics to Value Healthcare Investments that Reduce System-Level Risks: Example of Disease Elimination and Eradication.
Applied health economics and health policy·2026
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making.
Applied health economics and health policy·2025
Health Technology Assessment Lifecycle Concepts: A Scoping Review Outlining the Change in Policies to Manage Uncertainties Associated With Reimbursement of Medicines.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Cost-Effectiveness of Cilta-cel in Lenalidomide-Refractory Multiple Myeloma: An Analysis of the CARTITUDE-4 Trial.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
An Application of Iterative Health Economic Evaluation: An Update on the Early Cost Effectiveness of Whole-Genome Sequencing in Advanced Non-small-Cell Lung Cancer.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Does conventional cost-effectiveness analysis disadvantage treatments for severe disease? Evidence from U.S. value assessments.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Incorporating Equity Considerations Related to Financial Protection Through Extended Cost-Effectiveness Analysis: A Systematic Review.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
How Long Should We Wait? The Impact of Immature Data on Colorectal Cancer Decision Modeling.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
An investment too good to be true?: Reassessing the World Health Organization and World Bank return-on-investment estimates for pandemic preparedness.
Health economics, policy, and law·2026
The economics of decision-making in dementia care and related life-limiting illness: a narrative review.
Health economics review·2026
Money-Work: Science Funding as Relational Socioeconomics.
Social studies of science·2026
[The right to health and the "constitutionally necessary expenditure".]
Recenti progressi in medicina·2026
External validation of the budget impact analysis of the drug fingolimode in the treatment of multiple sclerosis.
Cost effectiveness and resource allocation : C/E·2026
Medicare Advantage Enrollment Increased Disproportionately In Chain-Owned Dialysis Facilities After The Cures Act.
Health affairs (Project Hope)·2025